Novartis receives USFDA approval for Eltrombopag drug
Novartis has received USFDA approval for eltrombopag drug (Promacta for oral suspension, Novartis) for the treatment of thrombocytopenia in paediatric patients. The approval was based […]
Approvals
Sun Pharma receives USFDA approval for XiminoTM
Sun Pharmaceutical Industries has received approval from USFDA for its new drug used for acne treatment XiminoTM extended-release capsules in strengths of 45 mg, 90 […]
DRL launches generic Pramipexole dihydrochloride in US market
Dr Reddy’s Laboratories has launched generic Pramipexole dihydrochloride extended-release tablets for treatment of Parkinson’s disease in the US market. The company has launched the tablets […]
Indoco Remedies plans expansion programme
Indoco Remedies is planning an expansion programme at its sterile ophthalmic manufacturing facility in Goa with an investment of Rs. 1250 million. The company is […]
Ajanta Pharma receives final approval for Monelukast
Ajanta Pharma has received final approval for its three ANDAs (Abbreviated New Drug Application) by USFDA for Montelukast tablets in the strength of 10 mg, […]
Aurobindo Pharma receives USFDA approval for Ibandronate Sodium Injection and Omeprazole
Aurobindo Pharma Ltd has received approval from the US Food & Drug Administration (USFDA) to manufacture and market Ibandronate Sodium Injection used in treatment of […]
Emcure Pharmaceuticals Hingenwadi plant receives USFDA ban
Emcure Pharmaceuticals had been barred exports from its Hinjewadi manufacturing plant in the western state of Maharashtra. According to USFDA, the manufacturing plant does not […]
Zydus Cadila receives USFDA approval for Pyridostigmine Bromide
Zydus Cadila has received final approval from the USFDA to market Pyridostigmine Bromide Tablets USP, 60 mg. The tablets are used in treatment of neurological […]
Aurobindo Pharma receives USFDA approval for metronidazole
Aurobindo Pharma has received USFDA approval to market Metronidazole tablets in USA. The company has received final approval from the US Food and Drug Administration […]
Aurobindo Pharma receives tentative approval from USFDA for Lacosamide
Aurobindo Pharma has received tentative approval from the US health regulator USFDA for its generic Lacosamide tablets used in treatment of partial seizures in epilepsy […]